DDInter948 DDInter1829
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Tolcapone is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinson's disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. Tolcapone is associated with a risk of hepatotoxicity.
Tolcapone {u} (Compound) resembles {v} (Compound) Tolmetin
Tolcapone {u} (Compound) resembles {v} (Compound) Entacapone
Tolcapone {u} (Compound) binds {v} (Gene) COMT
Tolcapone {u} (Compound) palliates {v} (Disease) Parkinson's disease
Tolcapone {u} (Compound) downregulates {v} (Gene) GRB7
Tolcapone {u} (Compound) causes {v} (Side Effect) Neoplasm malignant
Tolcapone {u} may cause a minor interaction that can limit clinical effects when taken with {v} Warfarin
Tolcapone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Promethazine
Tolcapone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Morphine
Tolcapone {u} may lead to a major life threatening interaction when taken with {v} Methylene blue
Tolcapone (Compound) resembles Tolmetin (Compound)
Tolcapone (Compound) resembles Entacapone (Compound)
Tolcapone (Compound) binds COMT (Gene)
Tolcapone (Compound) palliates Parkinson's disease (Disease)
Tolcapone (Compound) downregulates GRB7 (Gene)
Tolcapone (Compound) causes Neoplasm malignant (Side Effect)
Tolcapone may cause a minor interaction that can limit clinical effects when taken with Warfarin
Tolcapone may cause a moderate interaction that could exacerbate diseases when taken with Promethazine
Tolcapone may cause a moderate interaction that could exacerbate diseases when taken with Morphine
Tolcapone may lead to a major life threatening interaction when taken with Methylene blue